Effect of pioglitazone on urinary liver‐type fatty acid‐binding protein concentrations in diabetes patients with microalbuminuria
The DOI matches its Crossref record.
Abstract
Background: Urinary liver‐type fatty acid‐binding protein (L‐FABP) is a useful marker for renal tubulointerstitial injury. Pioglitazone is reported to be effective in early diabetic nephropathy. The aim of the present study was to determine whether pioglitazone affects urinary L‐FABP levels in diabetic nephropathy patients with microalbuminuria. Methods: Sixty‐eight patients with type 2 diabetes and microalbuminuria were randomized to a 12‐month treatment with pioglitazone (30 mg/d, n = 17), glibenclamide (5 mg/d, n = 18), voglibose (0.6 mg/d, n = 17), or nateglinide (270 mg/d, n = 16). Pre‐ and posttreatment urinary albumin excretion (UAE) and urinary L‐FABP concentrations were compared between the four treatment groups and 40 age‐matched healthy subjects. Results: Pretreatment UAE and urinary L‐FABP levels differed little between the four groups. UAE and urinary L‐FABP levels were significantly greater in the diabetes patients than in the healthy subjects (UAE: p < 0.001; L‐FABP: p < 0.01). After 6 and 12 months, UAE and urinary L‐FABP were significantly lower in the pioglitazone treatment group than in the other treatment groups (UAE: 6 months, p < 0.01 and 12 months, p < 0.001; L‐FABP: 6 months, p < 0.05 and 12 months, p < 0.01). Conclusions: Pioglitazone, but not glibenclamide, voglibose, or nateglinide, appears to be effective in reducing UAE and the urinary L‐FABP level, suggesting that pioglitazone has a specific role in ameliorating both glomerular and tubulointerstitial lesions associated with early diabetic nephropathy. Copyright © 2006 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 24
- 10.1111/j.1463-1326.2004.00382.x · DOI
- 10.1055/s-2004-830527 · doi:10.1055/s-2004-830527
- 10.1016/j.metabol.2004.06.016 · DOI
- 10.1016/S1056-8727(00)00124-0 · DOI
- 10.1016/j.metabol.2004.05.013 · DOI
- Phillips AO, 2002, Diabetic nephropathy: the central role of renal proximal tubular cells in tubulointerstitial injury, Histol Histopathol, 17, 247
- 10.1007/s11892-003-0013-1 · DOI
- 10.1016/S0002-9440(10)63384-6 · DOI · Paper page
- 10.1111/j.1523-1755.2004.00653.x · DOI · Paper page
- 10.1002/dmrr.473 · DOI
- 10.2337/diacare.26.8.2231 · DOI · Paper page
- 10.2337/diacare.25.4.658 · DOI
- 10.1111/j.1464-5491.2004.01272.x · DOI
- 10.1016/j.lab.2003.08.001 · DOI · Paper page
- 10.1111/j.1523-1755.2004.00624.x · DOI
- 10.1358/dnp.2003.16.2.740244 · DOI
- 10.1046/j.1523-1755.2002.00277.x · DOI
- 10.1681/ASN.2004040278 · DOI
- 10.1046/j.1523-1755.2001.00766.x · DOI · Paper page
- 10.1111/j.1523-1755.2004.00574.x · DOI
- 10.1097/01.ASN.0000068626.23485.E0 · DOI
- 10.1073/pnas.88.6.2051 · DOI · Paper page
- 10.1038/347645a0 · DOI · Paper page
- 10.1210/jc.2003-030861 · DOI · Paper page
Cited by
Palmer, S. C., Tendal, B., Mustafa, R. A., Vandvik, P. O., Li, S., Hao, Q., Tunnicliffe, D., Ruospo, M., Natale, P., Saglimbene, V., et al. (2021) · BMJ · doi:10.1136/bmj.m4573 · Cited by 679
Liver fatty acid-binding protein as a biomarker of acute kidney injury after cardiac surgery
Portilla, D., Dent, C., Sugaya, T., Nagothu, K. K., Kundi, I., Moore, P., Noiri, E., & Devarajan, P. (2008) · Kidney International · doi:10.1038/sj.ki.5002721 · Cited by 403
Self-citationQaseem, A., Humphrey, L. L., Sweet, D. E., Starkey, M., Shekelle, P., & for the Clinical Guidelines Committee of the American College of Physicians* (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-3-201202070-00011 · Cited by 400
Jha, R., Lopez-Trevino, S., Kankanamalage, H. R., & Jha, J. C. (2024) · Biomedicines · doi:10.3390/biomedicines12051098 · Cited by 144
“Therefore, increased levels of urinary FABPs, particularly L-FABP and H-FABP, have been observed in DKD patients, indicating tubular injury and thus represent potential biomarkers [118].”
BackgroundRados, D. V., Pinto, L. C., Remonti, L. R., Leitão, C. B., & Gross, J. L. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1001992 · Cited by 143
Metadata
- Authors
- Nakamura, T., Sugaya, T., Kawagoe, Y., Ueda, Y., & Koide, H.
- Venue
- Diabetes/Metabolism Research and Reviews
- Publisher
- Wiley
- Published
- 2006-02-28
- Volume
- 22
- Issue
- 5
- Pages
- 385-389
- ISSN
- 1520-7552 (ISSN-L)
- 1520-7560
- OpenAlex
- W1999899935
- Cited by
- 45
- References
- 0
- FWCI
- 2.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.